DSGN vs LMT · $214.0M cap vs P/E 20, rev $75.05B
Design Therapeutics Inc (DSGN) versus Lockheed Martin Corporation (LMT) — a side-by-side from cached financials, not a winner call.
Design Therapeutics Inc (DSGN) is a biotechnology company listed on US.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Latest reported DSGN revenue for 2025-09-30 was $0. Net income was -$53.8M. DSGN currently screens at market cap $214.0M.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
DSGN currently screens at market cap $214.0M. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Not investment advice. Open the DSGN and LMT stock pages for the full models.
Not investment advice.